EXEMESTANE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer. (Chemical Entities of Biological Interest Ontology, CHEBI_4953)
External Link https://dgidb.org/results?searchType=drug&searchTerms=EXEMESTANE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the EXEMESTANE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
CCDC148 coiled-coil domain containing 148 3.5288
TCL1A T-cell leukemia/lymphoma 1A 3.5288
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1 0.383565
AKR1C3 aldo-keto reductase family 1, member C3 0.371453
BGLAP bone gamma-carboxyglutamate (gla) protein 0.201646
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 0.190746
MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 0.172137
ESR2 estrogen receptor 2 (ER beta) 0.116334
IGF1R insulin-like growth factor 1 receptor 0.102284
PGR progesterone receptor 0.0928631
ESR1 estrogen receptor 1 0.0711451
TUBB1 tubulin, beta 1 class VI 0.0613704
ERBB2 erb-b2 receptor tyrosine kinase 2 0.0182839
NFE2L2 nuclear factor, erythroid 2-like 2 0.00419596
AR androgen receptor 0.00397835